- active not recruitingPHASE1, PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
This study is testing a new drug, ST101, for people with advanced cancers like breast cancer, melanoma, and glioblastoma. It aims to see if the drug is safe, how much to give, and if it could help shrink tumors. It's for adults whose cancer hasn't responded to other treatments.
United States · United Kingdom - active not recruitingPHASE2
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
This study looks at new cancer vaccines, SCIB1 and iSCIB1+, for advanced skin cancer (melanoma). They are being tested with standard treatments (nivolumab/ipilimumab or pembrolizumab) to see if they are safe and can help these treatments work better or for longer.
United Kingdom